WuXi Biologics (Cayman) WXIBF Stock
WuXi Biologics (Cayman) Price Chart
WuXi Biologics (Cayman) WXIBF Financial and Trading Overview
| WuXi Biologics (Cayman) stock price | 1.81 USD |
| Previous Close | 5.44 USD |
| Open | 6.1 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 5.96 - 6.1 USD |
| 52 Week Range | 4.67 - 10.84 USD |
| Volume | 10.5K USD |
| Avg. Volume | 366 USD |
| Market Cap | 25.52B USD |
| Beta (5Y Monthly) | 1.242145 |
| PE Ratio (TTM) | 39.734 |
| EPS (TTM) | 0.11 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
WXIBF Valuation Measures
| Enterprise Value | 22.06B USD |
| Trailing P/E | 39.734 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.671461 |
| Price/Book (mrq) | 0.7185172 |
| Enterprise Value/Revenue | 1.445 |
| Enterprise Value/EBITDA | 4.351 |
Trading Information
WuXi Biologics (Cayman) Stock Price History
| Beta (5Y Monthly) | 1.242145 |
| 52-Week Change | -28.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 10.84 USD |
| 52 Week Low | 4.67 USD |
| 50-Day Moving Average | 5.89 USD |
| 200-Day Moving Average | 6.63 USD |
WXIBF Share Statistics
| Avg. Volume (3 month) | 366 USD |
| Avg. Daily Volume (10-Days) | 1.05K USD |
| Shares Outstanding | 4.23B |
| Float | 3.63B |
| Short Ratio | N/A |
| % Held by Insiders | 14.12% |
| % Held by Institutions | 44.22% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 28.94% |
| Operating Margin (ttm) | 28.49% |
| Gross Margin | 44.03% |
| EBITDA Margin | 33.19% |
Management Effectiveness
| Return on Assets (ttm) | 5.80% |
| Return on Equity (ttm) | 13.20% |
Income Statement
| Revenue (ttm) | 15.27B USD |
| Revenue Per Share (ttm) | 3.66 USD |
| Quarterly Revenue Growth (yoy) | 37.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 5.07B USD |
| Net Income Avi to Common (ttm) | 4.42B USD |
| Diluted EPS (ttm) | 0.15 |
| Quarterly Earnings Growth (yoy) | 21.89% |
Balance Sheet
| Total Cash (mrq) | 8.71B USD |
| Total Cash Per Share (mrq) | 2.06 USD |
| Total Debt (mrq) | 4.42B USD |
| Total Debt/Equity (mrq) | 12.21 USD |
| Current Ratio (mrq) | 1.982 |
| Book Value Per Share (mrq) | 8.295 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.54B USD |
| Levered Free Cash Flow (ttm) | -594393984 USD |
Profile of WuXi Biologics (Cayman)
| Country | United States |
| State | N/A |
| City | Wuxi |
| Address | No. 108, Meiliang Road |
| ZIP | 214092 |
| Phone | N/A |
| Website | https://www.wuxibiologics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12373 |
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People's Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Q&A For WuXi Biologics (Cayman) Stock
What is a current WXIBF stock price?
WuXi Biologics (Cayman) WXIBF stock price today per share is 1.81 USD.
How to purchase WuXi Biologics (Cayman) stock?
You can buy WXIBF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for WuXi Biologics (Cayman)?
The stock symbol or ticker of WuXi Biologics (Cayman) is WXIBF.
Which industry does the WuXi Biologics (Cayman) company belong to?
The WuXi Biologics (Cayman) industry is Biotechnology.
How many shares does WuXi Biologics (Cayman) have in circulation?
The max supply of WuXi Biologics (Cayman) shares is 4.17B.
What is WuXi Biologics (Cayman) Price to Earnings Ratio (PE Ratio)?
WuXi Biologics (Cayman) PE Ratio is 16.45454600 now.
What was WuXi Biologics (Cayman) earnings per share over the trailing 12 months (TTM)?
WuXi Biologics (Cayman) EPS is 0.11 USD over the trailing 12 months.
Which sector does the WuXi Biologics (Cayman) company belong to?
The WuXi Biologics (Cayman) sector is Healthcare.